Z51.12 ICD-10-CM Code: Encounter for antineoplastic immunotherapy
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Coding at a Glance
- Tabular directives
- 1 Excludes1 · 2 Excludes2 · 1 code-also instruction
Inpatient Payment Groups (MS-DRG)
Potential MS-DRG participation — not a DRG assignment.
MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v44, Appendix B.
- MS-DRG 826 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC (MDC 17)
- MS-DRG 827 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC (MDC 17)
- MS-DRG 828 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC (MDC 17)
- MS-DRG 829 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC (MDC 17)
- MS-DRG 830 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC (MDC 17)
- MS-DRG 837 — CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC (MDC 17)
- MS-DRG 838 — CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT (MDC 17)
- MS-DRG 839 — CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC (MDC 17)
- MS-DRG 846 — CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC (MDC 17)
- MS-DRG 847 — CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC (MDC 17)
- MS-DRG 848 — CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC (MDC 17)
A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.
Coding instructions
Official Tabular Instructional Notes: the inclusion, exclusion and sequencing notes published for Z51.12 in the official ICD-10-CM tabular list, quoted as published.
Source: CMS/CDC — ICD-10-CM Tabular ListRelease: FY2027Effective: October 1, 2026
Trace:FY2027 changesChange historyRelease, file and checksum
Notes without a marker are published on Z51.12 itself; “inherited from” names the category or block whose note applies here.
Excludes1 — Not Coded Here
Conditions generally not reported together with this code (Excludes1) -- an error unless the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
- follow-up examination after treatment (Z08-Z09) Compare Z51.12 vs Z08 →
Source: inherited from Z51
Excludes2 — Not Included Here
Conditions not covered by this code, but which may be reported alongside it when both are present.
- encounter for chemotherapy and immunotherapy for nonneoplastic condition - code to condition inherited from Z51.1
- follow-up examination for medical surveillance after treatment (Z08-Z09) inherited from Z40-Z53Compare Z51.12 vs Z08 →
Code Also
Additional codes that may be required to fully describe the encounter.
- condition requiring care
Source: inherited from Z51
Coder workflow for Z51.12
MedCoder structured workflow — derived from this code’s own official record
Before you code Z51.12
- Confirm the reason for the encounter this Z code records: aftercare or a therapy encounter after the initial treatment of a disease or injury. Check whether the code may be reported as first-listed or principal — some Z codes are limited to one position — and do not report a history or status code for a condition documented as current. Z code categories and their reporting positions (Guidelines I.C.21.c.7, I.C.21.c.15).
- Check the Excludes1 note: if the documentation supports a condition named there, do not simply proceed with Z51.12. Excludes1 conditions are not reported together with this code unless the record shows they are unrelated (Guidelines I.A.12.a).
Choose the right path
- Does the documentation support a condition named in Z51.12’s Excludes1 note?
Yes → Do not simply proceed: review the excluded code. Both are reported only when the record shows the two conditions are unrelated.
No → Continue.
Consider Z51.12. Then review the Code Also note, and confirm the code is valid for the date of service in the Verify section.
Documentation check
- The provider’s diagnostic statement
- Codes are assigned from the provider’s documented diagnosis, not from clinical criteria, test values or a medication list (Guidelines I.A.19).
- The reason for the encounter
- Whether the code records the encounter’s purpose, a status, or a history — and whether it may be first-listed (Guidelines I.C.21.c).
Official instructions as workflow
Excludes1 — check before selecting Z51.12(1 note)
Coding workflow: If the documentation supports a condition named in this note, do not simply proceed with Z51.12: the two are not reported together. The one exception is when the record shows the two conditions are unrelated to each other.
See the official tabular notes · Guidelines I.A.12.a
Excludes2 — not part of Z51.12(2 notes)
Coding workflow: The conditions named in this note are not included in Z51.12. When the record documents both, both may be reported; the note is a boundary, not a prohibition.
See the official tabular notes · Guidelines I.A.12.b
Code Also — related condition(1 note)
Coding workflow: Review the related condition when both are documented and the instruction applies. A Code Also note does not fix sequencing; the order follows the circumstances of the encounter.
See the official tabular notes · Guidelines I.A.17
Coding decision scenarios
Pattern scenarios for this code’s structure — decision rules, not clinical cases
Documentation: Both the condition Z51.12 describes and a condition named in its Excludes1 note are documented for the same encounter.
Coding question: Can both codes be reported?
Path: Review the Excludes1 note and the excluded code, and look for a provider statement on whether the two conditions are related.
Reason: Excludes1 means the two are not coded together; the exception is when the record shows the conditions are unrelated to each other (Guidelines I.A.12.a).
Every row is derived from this code’s own record — its title, tabular notes, 7th-character family and same-category siblings — with fixed MedCoder wording; nothing is inferred about a patient. The official notes and guideline text are in the sections each row links to, and they control.
Code Overview
MedCoder summary Summary composed by MedCoder from this code's official ICD-10-CM record. The tabular instructional notes themselves appear verbatim below.
Indexed Clinical Terms (2)
Official source data — entries quoted as published, in the Index’s own lookup phrasing
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code. These are alphabetic-index entries shown as the Index writes them — lookup phrasing, not necessarily the wording of a final diagnosis.
Official Coding Guidelines
Official source data — quoted verbatim from the CMS/NCHS Official Guidelines
Official source data — quoted verbatim from the CMS/NCHS Official Guidelines
Verbatim excerpts from the ICD-10-CM Official Guidelines for Coding and Reporting (CMS/NCHS) that govern this code.
Chapter 2: Neoplasms (C00-D49 )
2) Patient admission/encounter chiefly for administration of antineoplastic chemotherapy, immunotherapy and radiation therapy If a patient admission/encounter is chiefly for the administration of chemotherapy, immunotherapy or external beam radiation therapy for the treatment of a neoplasm, assign code Z51.0, Encounter for antineoplastic radiation therapy, or Z51.11, Encounter for antineoplastic chemotherapy, or Z51.12, Encounter for antineoplastic immunotherapy as the first-listed or principal diagnosis. If the reason for the encounter is more than one type of antineoplastic therapy, code Z51.0 and codes from subcategory Z51.1 may be assigned together, in which case one of these codes would be reported as a secondary diagnosis.
Chapter 2: Neoplasms (C00-D49 )
3) Patient admitted for radiation therapy, chemotherapy or immunotherapy and develops complications When a patient is admitted for the purpose of external beam radiotherapy, immunotherapy or chemotherapy and develops complications such as uncontrolled nausea and vomiting or dehydration, the principal or first-listed diagnosis is Z51.0, Encounter for antineoplastic radiation therapy, or Z51.11, Encounter for antineoplastic chemotherapy, or Z51.12, Encounter for antineoplastic immunotherapy followed by any codes for the complications.
Chapter 21: Factors influencing health status and contact with health services (Z00-Z99)
Z31.81 Encounter for male factor infertility in female patient Z31.83 Encounter for assisted reproductive fertility procedure cycle Z31.84 Encounter for fertility preservation procedure Z34 Encounter for supervision of normal pregnancy Z39 Encounter for maternal postpartum care and examination Z38 Liveborn infants according to place of birth and type of delivery Z40 Encounter for prophylactic surgery Z42 Encounter for plastic and reconstructive surgery following medical procedure or healed injury Z51.0 Encounter for antineoplastic radiation therapy Z51.1- Encounter for antineoplastic chemotherapy and immunotherapy Z52 Donors of organs and tissues Except: Z52.9, Donor of unspecified organ or tissue Z76.1 Encounter for health supervision and care of foundling Z76.2 Encounter for health supervision and care of other healthy infant and child Z99.12 Encounter for respirator [ventilator] dependence during power failure
Chapter 2: Neoplasms (C00-D49 )
The only exception to this guideline is if the administration of chemotherapy, immunotherapy or external beam radiation therapy is chiefly responsible for occasioning the admission/encounter. In that case, assign the appropriate Z51.-- code as the first-listed or principal diagnosis, and the underlying diagnosis or problem for which the service is being performed as a secondary diagnosis.
Chapter 21: Factors influencing health status and contact with health services (Z00-Z99)
The aftercare codes are generally found in the following categories: Z42 Encounter for plastic and reconstructive surgery following medical procedure or healed injury Z43 Encounter for attention to artificial openings Z44 Encounter for fitting and adjustment of external prosthetic device Z45 Encounter for adjustment and management of implanted device Z46 Encounter for fitting and adjustment of other devices Z47 Orthopedic aftercare Z48 Encounter for other postprocedural aftercare Z49 Encounter for care involving renal dialysis Z51 Encounter for other aftercare and medical care
Decision Points
The directives on this code's own record, as a pre-claim checklist.
- 1 Code Also note — a second code may apply; the guidelines leave its sequencing to the circumstances of the encounter. See the Code Also notes
- 1 Excludes1 entry — codes named there are generally not reported together with this code (Guidelines I.A.12.a). See the Excludes1 notes
- 2 Excludes2 entries — those conditions are not part of this code and may be reported additionally when documented. See the Excludes2 notes
Checklist rows are derived from this code's own official directives; the wording of each check is MedCoder editorial. The official notes themselves are in the sections each row links to.
Verify Before Coding
- No Medicare Code Editor or MS-DRG Definitions Manual restrictions apply to this code.
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim in Claim Check.
Relationships & Classification
MedCoder structured relationships — computed from published CMS and AHRQ datasets
MS-DRG Grouper Relationships (FY2027)
Potential MS-DRG participation — not a DRG assignment.
FY2027 MS-DRG: not on the CMS CC/MCC list — as a secondary diagnosis this code does not change MS-DRG severity for that release.
Named in the grouper logic of 11 MS-DRGs: DRG 826 (MDC 17), DRG 827 (MDC 17), DRG 828 (MDC 17), DRG 829 (MDC 17), DRG 830 (MDC 17), DRG 837 (MDC 17), DRG 838 (MDC 17), DRG 839 (MDC 17), DRG 846 (MDC 17), DRG 847 (MDC 17) +1 more.
From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.
Clinical classification (AHRQ CCSR):FAC006 — Encounter for antineoplastic therapies (default).
Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.
Related Codes
Same clinical category (CCSR)
AHRQ's Clinical Classifications Software groups these diagnoses under the same clinical category (Encounter for antineoplastic therapies).
Z51.0 — Encounter for antineoplastic radiation therapy, Z51.11 — Encounter for antineoplastic chemotherapy
Same Index main term, other category
The ICD-10-CM Index to Diseases and Injuries files this code under the main term “Encounter”; these codes share that main term but sit in a different category of the Tabular List.
Z46.4 — Encounter for fitting and adjustment of orthodontic device (removal, orthodontic device), Z46.6 — Encounter for fitting and adjustment of urinary device (removal, urinary device), Z46.81 — Encounter for fitting and adjustment of insulin pump (removal, insulin pump), Z46.82 — Encounter for fitting and adjustment of non-vascular catheter (removal, non-vascular catheter), Z46.89 — Encounter for fitting and adjustment of other specified devices (removal, device, specified NEC), Z46.9 — Encounter for fitting and adjustment of unspecified device (removal, device), Z47.2 — Encounter for removal of internal fixation device (removal, internal fixation device), Z47.31 — Aftercare following explantation of shoulder joint prosthesis (joint prosthesis insertion following prior explantation of joint prosthesis, shoulder), Z47.32 — Aftercare following explantation of hip joint prosthesis (joint prosthesis insertion following prior explantation of joint prosthesis, hip), Z47.33 — Aftercare following explantation of knee joint prosthesis (joint prosthesis insertion following prior explantation of joint prosthesis, knee), Z69.010 — Encounter for mental health services for victim of parental child abuse (mental health services, child abuse, parental, victim), Z69.011 — Encounter for mental health services for perpetrator of parental child abuse (mental health services, child abuse, parental, perpetrator), Z69.020 — Encounter for mental health services for victim of non-parental child abuse (mental health services, child abuse, nonparental, victim), Z69.021 — Encounter for mental health services for perpetrator of non-parental child abuse (mental health services, child abuse, nonparental, perpetrator), Z69.11 — Encounter for mental health services for victim of spousal or partner abuse (mental health services, spousal or partner, abuse, victim), Z69.12 — Encounter for mental health services for perpetrator of spousal or partner abuse (mental health services, spousal or partner, abuse, perpetrator), Z69.81 — Encounter for mental health services for victim of other abuse (mental health services, abuse NEC, victim), Z69.82 — Encounter for mental health services for perpetrator of other abuse (mental health services, abuse NEC, perpetrator), Z71.83 — Encounter for nonprocreative genetic counseling (genetic, counseling, nonprocreative), Z76.81 — Expectant parent(s) prebirth pediatrician visit (pediatrician visit, by expectant parent), +93 more
Contextual Map
Every relationship of Z51.12 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Hierarchy
- Z00-Z99 — Chapter 21: Factors Influencing Health Status and Contact with Health Services (Z00-Z99) (Z00-Z99)[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z40-Z53 — Encounters for other specific health care[Hierarchy]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
Clinical classification (CCSR)
- FAC006 — Encounter for antineoplastic therapies[CCSR]— AHRQ CCSR for ICD-10-CM Diagnoses (HCUP)
MS-DRG Grouper (11)
- DRG 826 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC[MS-DRG]: “MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 827 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC[MS-DRG]: “MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 828 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC[MS-DRG]: “MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 829 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC[MS-DRG]: “MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 830 — MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC[MS-DRG]: “MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 837 — CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC[MS-DRG]: “CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 838 — CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT[MS-DRG]: “CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- DRG 839 — CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC[MS-DRG]: “CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC (MDC 17)”— CMS MS-DRG Definitions Manual (Appendix B) · FY2027
- and 3 more
MDC crossing
- MDC 17 — Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms[MDC crossing]: “Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs. 4,735 same-MDC procedures group here; browse them on the MDC page.”— CMS MS-DRG Definitions Manual · FY2027
Index entries
- Encounter (with health service) (for), immunotherapy for neoplasm[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2026
- Immunotherapy (encounter for), antineoplastic[Index term]— CMS ICD-10-CM Index to Diseases and Injuries · icd10cm-fy2026
Nearest codes (10)
- Z51 — Encounter for other aftercare and medical care[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z51.0 — Encounter for antineoplastic radiation therapy[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z51.1 — Encounter for antineoplastic chemotherapy and immunotherapy[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z51.11 — Encounter for antineoplastic chemotherapy[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z51.5 — Encounter for palliative care[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z51.6 — Encounter for desensitization to allergens[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z51.8 — Encounter for other specified aftercare[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- Z51.81 — Encounter for therapeutic drug level monitoring[Sibling]— CMS ICD-10-CM tabular structure · icd10cm-fy2026
- and 2 more
Change history
- FY2016 — In the code set at ICD-10-CM adoption [Change history]— CMS release files (code change ledger) · icd10cm-fy2016
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, title, tabular notes and index terms Official source data
- CMS/CDC ICD-10-CM FY2027 tabular list, index and tables, effective October 1, 2026 Release, file and checksum · Publisher’s page
- Coding guidelines Official source data
- ICD-10-CM Official Guidelines for Coding and Reporting (FY2027), quoted by section Release, file and checksum · Publisher’s page
- Claim edits Official source data
- CMS Definitions of Medicare Code Edits — v44.0 (October 2026) Release, file and checksum · Publisher’s page
- Inpatient payment groups Official source data
- CMS MS-DRG Definitions Manual (incl. Appendix B diagnosis index, Appendix C CC/MCC list, Appendix E procedure index) and IPPS Final Rule tables — v44 Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS ICD-10-CM release addenda, ingested release by release into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder structured relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Labels on this page: Official source data · MedCoder structured relationship · MedCoder explanation. How to read the labels · All data sources and release dates
Cite this page
Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.
MedCoder.ai. "Z51.12 — Encounter for antineoplastic immunotherapy." ICD-10-CM FY2027. https://medcoder.ai/icd10/code/z51.12-encounter-for-antineoplastic-immunotherapy
Change history
- FY2016 — October 1, 2015In the code set at ICD-10-CM adoptionEncounter for antineoplastic immunotherapy
No changes since FY2016 — additions, deletions, description changes and billable-status changes are tracked through FY2027, and none are recorded for this code. Note changes are tracked from FY2027 only.
Nearest Codes in This Family
Official ICD-10-CM classifications closest to Z51.12 in its code family, with their registry titles.
- Z51 — Encounter for other aftercare and medical care
- Z51.0 — Encounter for antineoplastic radiation therapy
- Z51.1 — Encounter for antineoplastic chemotherapy and immunotherapy
- Z51.11 — Encounter for antineoplastic chemotherapy
- Z51.5 — Encounter for palliative care
- Z51.6 — Encounter for desensitization to allergens
- Z51.8 — Encounter for other specified aftercare
- Z51.81 — Encounter for therapeutic drug level monitoring
- Z51.89 — Encounter for other specified aftercare
- Z51.A — Encounter for sepsis aftercare